Concentrix (NASDAQ:CNXC) Shares Down 7.2% – What’s Next?

Concentrix Corporation (NASDAQ:CNXC)’s share price was down 7.2% on Wednesday . The stock traded as low as $21.13 and last traded at $21.2090. Approximately 1,165,533 shares changed hands during trading, a decline of 31% from the average session volume of 1,680,328 shares. The stock had previously closed at $22.85.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on CNXC. Weiss Ratings reiterated a “sell (d)” rating on shares of Concentrix in a research note on Monday, April 27th. Zacks Research lowered Concentrix from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 2nd. Barrington Research dropped their price target on Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a report on Tuesday, June 30th. Canaccord Genuity Group cut their price objective on Concentrix from $55.00 to $45.00 and set a “buy” rating for the company in a research report on Tuesday, June 30th. Finally, Wall Street Zen lowered Concentrix from a “buy” rating to a “hold” rating in a research note on Saturday, March 28th. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $32.75.

Concentrix Stock Performance

The firm has a fifty day simple moving average of $25.21 and a 200-day simple moving average of $31.40. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 1.46. The stock has a market cap of $1.30 billion, a price-to-earnings ratio of -0.99, a P/E/G ratio of 0.43 and a beta of 0.47.

Concentrix (NASDAQ:CNXC) last released its earnings results on Monday, June 29th. The company reported $2.63 EPS for the quarter, missing the consensus estimate of $2.64 by ($0.01). Concentrix had a negative net margin of 13.16% and a positive return on equity of 19.82%. The firm had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.47 billion. During the same period last year, the business posted $2.70 earnings per share. The firm’s quarterly revenue was up 1.9% on a year-over-year basis. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. Analysts forecast that Concentrix Corporation will post 9.67 EPS for the current fiscal year.

Concentrix Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, August 4th. Shareholders of record on Friday, July 24th will be given a dividend of $0.36 per share. The ex-dividend date is Friday, July 24th. This represents a $1.44 dividend on an annualized basis and a yield of 6.8%. Concentrix’s dividend payout ratio is presently -6.75%.

Insider Activity

In related news, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the stock in a transaction that occurred on Wednesday, April 29th. The shares were sold at an average price of $22.25, for a total value of $133,500,000.00. Following the transaction, the insider directly owned 2,773,667 shares in the company, valued at $61,714,090.75. This represents a 68.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Andre S. Valentine acquired 2,500 shares of the business’s stock in a transaction that occurred on Thursday, April 9th. The stock was acquired at an average price of $27.95 per share, for a total transaction of $69,875.00. Following the completion of the acquisition, the chief financial officer directly owned 89,066 shares of the company’s stock, valued at $2,489,394.70. This trade represents a 2.89% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.90% of the stock is currently owned by company insiders.

Institutional Trading of Concentrix

Institutional investors have recently bought and sold shares of the business. Thompson Investment Management Inc. grew its stake in shares of Concentrix by 36.9% during the fourth quarter. Thompson Investment Management Inc. now owns 216,154 shares of the company’s stock worth $8,988,000 after purchasing an additional 58,251 shares during the period. Invenomic Capital Management LP lifted its stake in Concentrix by 19.7% in the third quarter. Invenomic Capital Management LP now owns 822,345 shares of the company’s stock valued at $37,951,000 after buying an additional 135,429 shares during the period. Hussman Strategic Advisors Inc. lifted its stake in Concentrix by 100.0% in the fourth quarter. Hussman Strategic Advisors Inc. now owns 84,000 shares of the company’s stock valued at $3,493,000 after buying an additional 42,000 shares during the period. Pzena Investment Management LLC boosted its holdings in Concentrix by 32.3% during the fourth quarter. Pzena Investment Management LLC now owns 2,927,196 shares of the company’s stock worth $121,713,000 after buying an additional 714,604 shares during the last quarter. Finally, Jupiter Asset Management Ltd. bought a new position in Concentrix during the fourth quarter worth about $19,385,000. Institutional investors and hedge funds own 90.34% of the company’s stock.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.